Status:
COMPLETED
Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Medical Research Council Unit, The Gambia
Department of State for Health and Social Welfare, The Gambia
Conditions:
Malaria
Eligibility:
FEMALE
Phase:
PHASE3
Brief Summary
Malaria is particularly harmful during pregnancy causing anemia in the mother and low birth weight which, in turn, increases infant mortality. Thus, the World Health Organization (WHO) now recommends ...
Detailed Description
Objective The objective of this study was to determine whether intermittent preventative treatment (IPTp) with sulfadoxine-pyrimethamine (SP) reduced the prevalence of anemia and low birth weight in ...
Eligibility Criteria
Inclusion
- Multigravid pregnancy.
- Residence in study area.
- Informed consent.
Exclusion
- Allergy to sulfonamides.
- Chronic illness.
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
September 1 2004
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00120809
Start Date
July 1 2002
End Date
September 1 2004
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Research Council Laboratories
Banjul, The Gambia, PO Box 273